期刊文献+

肝郁脾虚证患者口服加味逍遥散后血清阿魏酸药动学研究 被引量:8

Pharmacokinetics of ferulic acid in serum of patients with liver-qi stagnation and spleen insufficiency after oral administration of Jiaweixiaoyao Powder
原文传递
导出
摘要 目的观察加味逍遥散汤剂中当归来源的阿魏酸在肝郁脾虚证患者体内的药代动力学特征。方法选取肝郁脾虚证患者10例,测定患者在口服加味逍遥散汤剂5、10、15、30、60、90、120 m in的血清样本中阿魏酸的浓度。结果肝郁脾虚证患者阿魏酸的血药浓度-时间曲线符合二室开放模型,其吸收半衰期为(15.61±9.77)m in,分布半衰期为(41.54±23.95)m in,消除半衰期为(91.01±64.14)m in。结论明确阿魏酸在肝郁脾虚证患者体内的药代动力学特征,为临床用药提供一定的参考作用。 Objective To observe the pharmacokinetic characteristics of ferulic acid (from Radix Angelicae Sinensis ) of decocted Jiaweixiaoyao Powder in patients with liver-qi stagnation and spleen insufficiency. Methods Ten patients with liver-qi stagnation and spleen insufficiency were chosen and given Jiaweixiaoyao Powder orally. At the time of 5, 10, 15,30, 60, 90 and 120 min, the concentration of ferulic acid in the serum samples was determined. Results The concentration-time curve of ferulic acid in serum of patients with liver-qi stagnation and spleen insufficiency was shown to fit a double compartment open model, t1/2Ka was ( 15.61 ± 9.77) min, t1/2α was (41.54 ± 23.95) min, and t1/2 was (91. 01 ± 64. 14 ) min. Conclusion The pharmacokinetic characteristics of ferulic acid is understood in the serum of patients with liver-qi stagnation and spleen insufficiency, which will play a reference role in clinical application.
出处 《北京中医药大学学报》 CAS CSCD 北大核心 2006年第10期694-697,712,共5页 Journal of Beijing University of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(No.39770886) 高等学校骨干教师资助计划
关键词 阿魏酸 加味逍遥散 肝郁脾虚证 药代动力学 ferulic acid Jiaweixiaoyao Powder syndrome of liver-qi stagnation and spleen insufficiency phannacokinetics
  • 相关文献

参考文献13

二级参考文献54

共引文献220

同被引文献85

引证文献8

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部